TR Capital and Shenzhen Capital Group have backed the spin-out of six healthcare assets held by China focused GP Huagai Capital into a RMB800 million ($125 million) renminbi-denominated continuation fund.
The transaction was described as a hybrid renminbi and US dollar qualified foreign limited partner (QFLP) secondary, presumably because Shenzhen Capital participated via a local currency vehicle while...
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
Best & Less Group (BLG), an Australian baby, kids and womenswear retailer, has raised A$60 million ($44 million) through a domestic IPO, facilitating a partial exit for majority owner Allegro Funds Group.
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
B Capital Group has hired Sheila Patel, formerly the Singapore-based chairman of Goldman Sachs Asset Management, as a vice president amid a concerted Asian expansion drive.